ArticleCureus2026
Hypercalcemia, Staghorn Calculus and Xanthogranulomatous Pyelonephritis: A Diagnostic Challenge Unmasking Metastatic Urothelial Carcinoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthogranulomatous pyelonephritis (XGP) is a rare, chronic inflammatory renal condition often associated with urinary tract obstruction, nephrolithiasis, and recurrent infection. Diagnostically, it can mimic malignancy on both clinical presentation and imaging. A 65-year-old woman presented with a three-week history of abdominal pain, fever, and giddiness. Cross-sectional imaging demonstrated a left staghorn calculus with hydronephrosis and features consistent with XGP and pyonephrosis. She underwent urgent percutaneous nephrostomy (PCN) with drainage of purulent material. During admission, she developed acute confusion and was found to have severe hypercalcemia (albumin-corrected calcium 3.7 mmol/L) with suppressed parathyroid hormone (PTH) and elevated parathyroid hormone-related protein (PTHrP). Positron emission tomography (PET)-CT imaging revealed widespread fluorodeoxyglucose (FDG)-avid lesions involving the left kidney, para-aortic lymph nodes, lungs, myocardium, and rectum. These findings were collectively worrisome for either disseminated infection or underlying malignancy. Tissue biopsy of a para-aortic lymph node demonstrated poorly differentiated metastatic carcinoma with squamous differentiation, ultimately establishing the presence of metastatic urothelial carcinoma, with involvement of the left kidney, lymph nodes, and lungs. The patient was referred for palliative systemic chemotherapy. This case illustrates the complex interplay of multiple pathologies: Staghorn calculi not only leads to complications such as XGP and obstructive pyonephrosis, but is also associated with urothelial carcinoma. Through production of PTHrP, humoral hypercalcemia of malignancy further propagates nephrolithiasis. The case highlights the diagnostic challenge of distinguishing XGP and its infective complications from urological malignancy, and underscores the critical role of PTHrP in prompting evaluation for occult malignancy. Maintaining diagnostic vigilance is crucial, given the possible co-existence of multiple pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.